Previous 10 | Next 10 |
Recent news releases related news releases and press releases from 08/01/23 07:00:00 on US and Canada Markets.
BOSTON, Aug. 01, 2023 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (“Atea”), a clinical-stage biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for serious viral diseases, today announced that it will host a live confe...
Veteran technology leader, former ecommerce exec tapped to propel BigCommerce’s push to enterprise ecommerce leadership BigCommerce (Nasdaq: BIGC), a leading Open SaaS ecommerce platform for fast-growing and established B2C and B2B brands, today announced the company has hired te...
NEW YORK and SAN DIEGO, Aug. 01, 2023 (GLOBE NEWSWIRE) -- Zentalis ® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company discovering and developing clinically differentiated small molecule therapeutics targeting fundamental biological pathways of cancers, tod...
R evolution Medicines Expect s to Conduct Late-Stage Development of RAS(ON) I nhibitor Drug C andidate Pipeline Supported by Fortified Balance Sheet Agreement is the Result of a Rigorous Process Conducted by Independe...
Conference call and webcast at 8:30am ET Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a growth-oriented biopharmaceutical company committed to improving patients’ lives by developing and commercializing innovative products across a range of therapies, today announced that the C...
HAMILTON LANE INCORPORATED REPORTS FIRST QUARTER FISCAL 2024 RESULTS, WITH MANAGEMENT & ADVISORY FEES GROWING BY 23% AND ASSETS UNDER MANAGEMENT GROWING BY 8% YEAR-OVER-YEAR HAMILTON LANE INCORPORATED REPORTS FIRST QUARTER FISCAL 2024 RESULTS, WITH MANAGEMENT & ADVISORY FEES GRO...
Evogene Schedules Second Quarter 2023 Financial Results Release & Conference Call for August 17, 2023 Evogene Schedules Second Quarter 2023 Financial Results Release & Conference Call for August 17, 2023 PR Newswire Conference call scheduled for 9:00 AM ET ...
Total deal size of approximately ~$650M, including over $150M in upfront and near-term milestones Neuraxpharm’s dedicated neurology focus and established European presence makes them an attractive partner for BRIUMVI’s European launch, targeted within the next six months ...
SiriusXM Reports Second Quarter 2023 Operating and Financial Results PR Newswire NEW YORK , Aug. 1, 2023 /PRNewswire/ -- SiriusXM (NASDAQ: SIRI) today reported operating and financial results for the second quarter 2023, which have been posted to the Investor Rel...
TARRYTOWN, N.Y., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced the winners of the 11th annual Regeneron Prize for Creative Innovation, a competition designed to honor exceptional talent and originality in biomedical research. Each year, Regeneron...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
9.37%Change Percent:
Teleperformance SA ADR Company Name:
TLPFY Stock Symbol:
OTCMKTS Market: